查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1247461

2023-2030 年術前計劃軟件的全球市場

Global Preoperative Surgical Planning Software Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

全球術前規劃軟件市場預計將出現有利可圖的增長，到 2022 年將達到 9720 萬美元，到 2030 年將達到 1.5787 億美元。 在預測期內（2023-2030 年），該市場的複合年增長率為 6.3%。

術前規劃軟件可幫助外科醫生為患者確定最佳治療和手術方案。 將您患者的歷史數據、診斷數據和其他重要數據輸入該軟件，該軟件將為您的患者提供理想的手術方式。 術前規劃軟件提供簡化的手術方案，以提高手術成功率。 該軟件用於骨科手術、牙科手術、神經外科和重建手術等手術。 Medtronic Plc、Stryker Corporation、WishBone Medical Inc.、Zimmer Biomet、Siemens AG、Brainlab AG 是市場上的主要參與者。

市場動態

骨科手術越來越受歡迎

在預測期內，對術前規劃軟件的需求不斷增長，正在推動全球市場的增長。 由於全球骨科手術數量的增加，術前計劃軟件市場預計將出現高速增長。 例如，根據美國骨科醫師學會的數據，美國每年大約進行一百萬次膝關節和髖關節置換手術。 由於骨骼和肌肉疼痛問題日益嚴重，對髖關節和膝關節置換術等骨科手術的需求量很大。 因此，上述因素正在推動骨科領域的市場主導地位。

產品召回的增加預計將阻礙市場增長

術前手術計劃軟件是一種複雜的軟件，它使用許多不同類型的組件，並且可能會因其複雜性而開始出現故障。 由於這些複雜性，軟件通常無法提供術前計劃協議。 例如，2020 年 2 月，美國食品和藥物管理局 (U.S.FDA) 報告召回 Zimmer Biomet 的 ROSA Brain 3.0。 該軟件無法提供足夠的患者橫截面圖像。 使用 ROSA Brain 軟件時，圖像無法在 2D 和 3D 視圖中正確顯示。 錯誤生成的數據很可能導致錯誤的手術計劃。

COVID-19 影響分析

除了 COVID 之前、COVID 和 COVID 之後的情況外，COVID-19 分析還包括價格動態（包括與 COVID 之前的情況相比，大流行期間和之後的價格變動）、供需範圍（交易限制） 、封鎖以及隨後由於問題導致的供需變化）、政府舉措（政府機構為振興市場、部門和行業而採取的舉措）、製造商的戰略舉措（製造商為緩解 COVID 問題而採取的舉措）。

內容

第 1 章研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 片段類型
  • 按應用程序摘錄
  • 最終用戶的片段
  • 區域摘要

第 4 章動力學

  • 影響因子
    • 司機
      • 技術日新月異
      • 骨科手術領域的受傷和手術數量增加
    • 約束因素
      • 監管機構召回產品的數量增加
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 當前的 COVID-19 情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章按類型

  • 基於雲
  • 本地

第八章應用

  • 骨科
  • 骨科
  • 神經外科
  • 牙科/牙齒矯正
  • 其他

第 9 章最終用戶

  • 醫院
  • 門診手術系統
  • 專業中心
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場分析/份額分析
  • 併購分析

第12章公司簡介

  • 美敦力公司
    • 公司簡介
    • 產品組合和說明
    • 財務摘要
    • 主要發展
  • Stryker Corporation
  • WishBone Medical Inc.
  • Zimmer Biomet
  • Siemens AG
  • Brainlab AG
  • GE Healthcare
  • Renishaw Plc
  • mediCAD Hectec GmbH
  • Peek Health S.A.

第13章 附錄

簡介目錄
Product Code: HCIT1348

Market Overview

The global preoperative surgical planning software market reached US$ 97.20 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 157.87 million by 2030. The market is growing at a CAGR of 6.3% during the forecast period (2023-2030).

Preoperative surgical planning software provides helps surgeons to decide the best treatment and surgical options for the patients. When the software is fed with the patient's historical data, diagnostics data, and other essential data, the software gives an ideal surgical approach to the patient. The preoperative surgical planning software gives a streamlined surgical protocol to increase the success rate of the surgery. This software is used for surgeries like orthopedic surgeries, dental surgery, neuro-surgery, reconstruction surgery, and others. Medtronic Plc, Stryker Corporation, WishBone Medical Inc., Zimmer Biomet, Siemens AG, and Brainlab AG are the major players in the market.

Market Dynamics

The increasing prevalence of orthopedic surgeries

The growing demand for preoperative surgical planning software is driving growth in the global market over the forecast period. The preoperative surgical planning software market is expected to witness high growth owing to the increasing number of orthopedic surgeries across the globe. For instance, according to the American Board of Orthopedic Surgery, around 1 million knee and hip arthroplasties were performed in the U.S. every year. Orthopedic surgeries like hip and knee replacement/arthroplasty are highly in demand owing to increasing bone and muscle pain problems. Therefore, the above-mentioned factors help the orthopedic surgery segment to dominate the market.

Rising product recalls are expected to hinder the market growth

Preoperative surgical planning software is a complex software that uses various types of components that may start malfunctioning because of complexities. Owing to these complexities the software often fails to provide the surgical preplanning protocol. For instance, in February 2020, the U.S. Food and Drug Administration (U.S.FDA), reported the recall of ROSA Brain 3.0 manufactured by Zimmer Biomet. The software was not able to provide the proper cross-sectional images of the patients. The images were not properly displayed in two and three-dimensional views when using ROSA Brain software. The wrong-generated data was very likely to give incorrect surgery planning.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it with pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global preoperative surgical planning software market is segmented based on type, application, end user, and region.

On basis of the Type, Orthopedic surgery is expected to hold the largest share

Cloud-based, a type segment of preoperative surgical planning software, dominates the global market due to its versatility, cost-effectiveness, and high demand in the surgical market. The increasing product launches of cloud-based software are expected to accelerate the preoperative surgical planning software market over the forecast period. For instance, in April 2021, Corin Group launched the new OPSInsight preoperative planning software for total hip arthroplasty (THA). The product is a cloud-based platform using Corin's next-generation Optimized Positioning System (OPS) technology. These advantages of cloud-based software highly contribute to the factors that help the product segment to dominate the market.

Geographical Analysis

Growing demand for preoperative surgical planning software in Asia Pacific

The growing demand for preoperative surgical planning software in developing countries, especially in Asia-Pacific, creates opportunities for manufacturers to expand their operations in these regions. The region has many manufacturers and its strong economic growth has led to increased demand by the hospitals and ambulatory surgical centers that are highly technology equipped thereby boosting the demand for preoperative surgical planning software. The region's rapidly growing population and urbanization, leading to increased demand for streamlined surgical procedures, is also a factor. Growing awareness about the benefits and AI integration contributes to the market's growth in the region. Furthermore, the above-stated factors depict Asia-Pacific's fastest growth in the market.

Competitive Landscape

The major global players in the market include Medtronic Plc, Stryker Corporation, WishBone Medical Inc., Zimmer Biomet, Siemens AG, Brainlab AG, GE Healthcare, Renishaw Plc, mediCAD Hectec GmbH, and Peek Health S.A.

Why Purchase the Report?

  • To visualize the global preoperative surgical planning software market segmentation based on type, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of preoperative surgical planning software market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global preoperative surgical planning software market report would provide approximately 61 tables, 58 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rapid growth in technological advancements
      • 4.1.1.2. Increasing cases of orthopedic injuries and related surgeries
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. Rising number of product recalls by regulatory authorities
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. XX
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Cloud-based*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. On-premise

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic Surgery*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedic Surgery
  • 8.4. Neurosurgery
  • 8.5. Dental and Orthodontics
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Systems
  • 9.4. Specialty Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Stryker Corporation
  • 12.3. WishBone Medical Inc.
  • 12.4. Zimmer Biomet
  • 12.5. Siemens AG
  • 12.6. Brainlab AG
  • 12.7. GE Healthcare
  • 12.8. Renishaw Plc
  • 12.9. mediCAD Hectec GmbH
  • 12.10. Peek Health S.A.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us